Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

73 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Feasibility and Tolerability of Adjuvant Capecitabine-Based Chemoradiation in Patients With Breast Cancer and Residual Disease After Neoadjuvant Chemotherapy: A Prospective Clinical Trial.
Balbach ML, Sherry AD, Rexer BN, Abramson VG, Niermann KJ, Johnson CR, Park BH, Mayer IA, Chakravarthy AB. Balbach ML, et al. Among authors: chakravarthy ab. Int J Radiat Oncol Biol Phys. 2024 Apr 1;118(5):1262-1270. doi: 10.1016/j.ijrobp.2023.06.076. Epub 2023 Jul 16. Int J Radiat Oncol Biol Phys. 2024. PMID: 37433376
Systemic Inflammation After Radiation Predicts Locoregional Recurrence, Progression, and Mortality in Stage II-III Triple-Negative Breast Cancer.
Sherry AD, von Eyben R, Newman NB, Gutkin P, Mayer I, Horst K, Chakravarthy AB, Rafat M. Sherry AD, et al. Among authors: chakravarthy ab. Int J Radiat Oncol Biol Phys. 2020 Sep 1;108(1):268-276. doi: 10.1016/j.ijrobp.2019.11.398. Epub 2019 Dec 3. Int J Radiat Oncol Biol Phys. 2020. PMID: 31809877 Free PMC article.
A novel AIF tracking method and comparison of DCE-MRI parameters using individual and population-based AIFs in human breast cancer.
Li X, Welch EB, Arlinghaus LR, Chakravarthy AB, Xu L, Farley J, Loveless ME, Mayer IA, Kelley MC, Meszoely IM, Means-Powell JA, Abramson VG, Grau AM, Gore JC, Yankeelov TE. Li X, et al. Among authors: chakravarthy ab. Phys Med Biol. 2011 Sep 7;56(17):5753-69. doi: 10.1088/0031-9155/56/17/018. Epub 2011 Aug 12. Phys Med Biol. 2011. PMID: 21841212 Free PMC article.
DCE-MRI analysis methods for predicting the response of breast cancer to neoadjuvant chemotherapy: pilot study findings.
Li X, Arlinghaus LR, Ayers GD, Chakravarthy AB, Abramson RG, Abramson VG, Atuegwu N, Farley J, Mayer IA, Kelley MC, Meszoely IM, Means-Powell J, Grau AM, Sanders M, Bhave SR, Yankeelov TE. Li X, et al. Among authors: chakravarthy ab. Magn Reson Med. 2014 Apr;71(4):1592-602. doi: 10.1002/mrm.24782. Epub 2013 May 9. Magn Reson Med. 2014. PMID: 23661583 Free PMC article. Clinical Trial.
Multiparametric magnetic resonance imaging for predicting pathological response after the first cycle of neoadjuvant chemotherapy in breast cancer.
Li X, Abramson RG, Arlinghaus LR, Kang H, Chakravarthy AB, Abramson VG, Farley J, Mayer IA, Kelley MC, Meszoely IM, Means-Powell J, Grau AM, Sanders M, Yankeelov TE. Li X, et al. Among authors: chakravarthy ab. Invest Radiol. 2015 Apr;50(4):195-204. doi: 10.1097/RLI.0000000000000100. Invest Radiol. 2015. PMID: 25360603 Free PMC article.
Neoadjuvant concurrent paclitaxel and radiation in stage II/III breast cancer.
Chakravarthy AB, Kelley MC, McLaren B, Truica CI, Billheimer D, Mayer IA, Grau AM, Johnson DH, Simpson JF, Beauchamp RD, Jones C, Pietenpol JA. Chakravarthy AB, et al. Clin Cancer Res. 2006 Mar 1;12(5):1570-6. doi: 10.1158/1078-0432.CCR-05-2304. Clin Cancer Res. 2006. PMID: 16533783
73 results